Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
DiscGenics
AddedFeb 15, 2024
UpdatedJun 18, 2026
DiscGenics

DiscGenics

Series C

DiscGenics: Developing regenerative therapies for spinal degenerative diseases to alleviate pain.

HQ
Salt Lake City, UT, US
Founded
2007
Overview
Compare
Fundraising
Employees
Website

DiscGenics, founded with the mission to improve the lives of those suffering from degenerative diseases of the spine, focuses on developing regenerative therapies. The company aims to revolutionize treatment for chronic back pain through specialized therapeutic progenitor cells, known as Discogenic Cells. Their core products are designed to alleviate pain and restore function in patients, targeting a significant market of individuals affected by spinal degenerative conditions.

Notable figures associated with DiscGenics include its team of pioneering scientists and medical experts dedicated to advancing spinal therapy. The company has attracted significant investment from leading venture capital firms and healthcare investors. Key achievements include successful clinical trials and regulatory milestones that underscore their innovative approach. DiscGenics' impact lies in its potential to transform the standard of care for millions suffering from chronic back pain, offering a promising alternative to conventional treatments.

DiscGenics - Similar Companies

InGeneron logo

InGeneron

ingeneron.com

Spinogenix logo

Spinogenix

spinogenix.com

Spine BioPharma logo

Spine BioPharma

spinebiopharma.com

Juventas Therapeutics logo

Juventas Therapeutics

juventasinc.com

Spinal Restoration logo

Spinal Restoration

Genascence logo

Genascence

genascence.com

Spheringenics logo

Spheringenics

Endogena Therapeutics logo

Endogena Therapeutics

Stemgenics logo

Stemgenics

stemgenics.com

Histogen logo

Histogen

histogen.com

Amplicore logo

Amplicore

Gentis logo

Gentis

Vascugen logo

Vascugen

vascugen.com

Convalesce logo

Convalesce

convalesce.co

Caeregen Therapeutics logo

Caeregen Therapeutics

caeregen.com

DiscGenics - Quick Facts

Who are DiscGenics' competitors?

Companies similar to DiscGenics include InGeneron, Spinogenix, Spine BioPharma and Juventas Therapeutics.

When was DiscGenics founded?

DiscGenics was founded in 2007.

Where is DiscGenics' headquarters located?

DiscGenics' headquarters is located in Salt Lake City, UT, US.

When was DiscGenics' last funding round?

DiscGenics' most recent funding round was for $50M (USD) in August 2020.

How much has DiscGenics raised to-date?

As of Aug 25, 2020, DiscGenics has raised a total of $68M (USD).

How many employees does DiscGenics have?

DiscGenics has 52 employees as of Feb 5, 2024.

DiscGenics - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Regenerative Therapies
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 8690Other human health activities
Show 19 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 621000Ambulatory Health Care Services
  • 621500Medical and Diagnostic Laboratories
  • 621510Medical and Diagnostic Laboratories
  • 621511Medical Laboratories
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8070Medical And Dental Laboratories
  • 8071Medical Laboratories
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified